Article Text

Download PDFPDF
No temporal association between influenza outbreaks and invasive pneumococcal infections
  1. Andre Michael Toschke1,2,
  2. Stephan Arenz1,
  3. Rüdiger von Kries1,
  4. Wolfram Puppe3,
  5. Josef A I Weigl3,
  6. Michael Höhle4,
  7. Ulrich Heininger5
  1. 1
    Institute for Social Pediatrics and Adolescent Medicine, Ludwig-Maximilians University Munich, Munich, Germany
  2. 2
    Division of Health and Social Care Research, King’s College London, London, UK
  3. 3
    Pediatric Infectious Diseases, University Children’s Hospital Kiel, Kiel, Germany
  4. 4
    Department of Statistics, Ludwig-Maximilians University Munich, Munich, Germany
  5. 5
    Division of Pediatric Infectious Diseases, University Children’s Hospital Basel, Basel, Switzerland
  1. Professor Ulrich Heininger, University Children’s Hospital Basel, PO Box 4005, Basel, Switzerland; Ulrich.Heininger{at}unibas.ch

Footnotes

  • Competing interests: Rüdiger von Kries is conducting a surveillance study on invasive pneumococcal infections in children in Germany funded by the manufacturer of a 7-valent pneumococcal vaccine, Prevenar (Wyeth) and – on a few occasions – has accepted honoraria for lectures given at meetings sponsored by Wyeth. Ulrich Heininger is a member of the Prevenar Advisory Board of Wyeth/Switzerland.

  • Funding: The surveillance of invasive pneumococcal infections in children in Germany was supported by Wyeth Pharma Germany, Münster and by a grant (FKZ 01KI0213) for PID-ARI.net (Pediatric Infectious Diseases Network on Acute Respiratory Tract Infections) awarded by the Bundesministerium für Forschung (BMBF).

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests: Rüdiger von Kries is conducting a surveillance study on invasive pneumococcal infections in children in Germany funded by the manufacturer of a 7-valent pneumococcal vaccine, Prevenar (Wyeth) and – on a few occasions – has accepted honoraria for lectures given at meetings sponsored by Wyeth. Ulrich Heininger is a member of the Prevenar Advisory Board of Wyeth/Switzerland.

  • Funding: The surveillance of invasive pneumococcal infections in children in Germany was supported by Wyeth Pharma Germany, Münster and by a grant (FKZ 01KI0213) for PID-ARI.net (Pediatric Infectious Diseases Network on Acute Respiratory Tract Infections) awarded by the Bundesministerium für Forschung (BMBF).

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Atoms
    Howard Bauchner, Editor-in-Chief